Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nasopharyngitis
ADR ID BADD_A02978
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.13      Upper respiratory tract infections
11.01.13.002      Nasopharyngitis
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.03      Upper respiratory tract infections NEC
22.07.03.002      Nasopharyngitis
Description Inflammation of the NASOPHARYNX, usually including its mucosa, related lymphoid structure, and glands. [MeSH]
MedDRA Code 10028810
MeSH ID D009304; D003080; D003139
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute nasopharyngitis | Acute nasopharyngitis (common cold) | Catarrhal lumps | Chronic nasopharyngitis | Cold | Cold symptoms | Common cold | Common cold syndrome | Febrile cold (excl flu like illness) | Head cold | Nasopharyngitis | Pyrexial cold | Rhinopharyngitis | Nasopharyngitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01662Pamidronic acid--
BADD_D01668Pantoprazole--
BADD_D01676Paricalcitol--
BADD_D01679Paroxetine--
BADD_D01682Paroxetine impurity a--
BADD_D01684Pasireotide--
BADD_D01685Pasireotide diaspartate--
BADD_D01687Pazopanib--
BADD_D01690Pegaptanib--
BADD_D01698Pegloticase--
BADD_D01704Pemirolast potassium--
BADD_D01739Perindopril--
BADD_D01740Perindopril erbumine--
BADD_D01744Pertuzumab--
BADD_D01773Pimecrolimus--
BADD_D01785Pitavastatin calcium--
BADD_D01786Pixantrone--
BADD_D01796Polyoxyethylene--
BADD_D01798Pomalidomide--
BADD_D01799Ponatinib--
BADD_D01800Ponatinib hydrochloride--
BADD_D01804Posaconazole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01824Pravastatin--
BADD_D01835Pregabalin--
BADD_D01852Progesterone--
BADD_D01874Prucalopride--
BADD_D01888Quetiapine--
BADD_D01906Raltegravir potassium--
BADD_D01912Ranibizumab--
The 10th Page    First    Pre   10 11 12 13    Next   Last    Total 13 Pages
ADReCS-Target
ADR Term Drug Name Target